1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Home Office Personnel

  1. Clinical Affairs

    Anonymous board for Clinical Affairs personnel
    Discussions:
    3
    Messages:
    8
    RSS
  2. Compliance

    Anonymous board for Compliance
    Discussions:
    4
    Messages:
    25
    RSS
  3. Medical Affairs

    Anonymous board for Medical Affairs personnel
    Discussions:
    2
    Messages:
    5
    RSS
  4. Medical Education

    Anonymous board for Medical Education personnel
    Discussions:
    3
    Messages:
    4
    RSS
  5. Sales Training

    Anonymous board for Sales Training personnel
    Discussions:
    6
    Messages:
    11
    RSS